FWG Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,308
Closed -$278K 110
2023
Q4
$278K Hold
3,308
0.17% 87
2023
Q3
$242K Hold
3,308
0.16% 81
2023
Q2
$267K Buy
3,308
+8
+0.2% +$638 0.17% 81
2023
Q1
$274K Sell
3,300
-416
-11% -$34.5K 0.2% 65
2022
Q4
$319K Buy
3,716
+16
+0.4% +$1.27K 0.22% 63
2022
Q3
$228K Buy
+3,700
New +$233K 0.17% 78

Other funds holding GILD

FWG Holdings's GILD Position: Q1 2024 in Review

FWG Holdings sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 3,308 shares — an estimated $278K sold.

FWG Holdings first reported a position in GILD in Q3 2022 and held it in 6 quarters. The position peaked at $319K in Q4 2022. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • FWG Holdings reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • FWG Holdings sold 3,308 Gilead Sciences shares in Q1 2024, an estimated $278K.
  • FWG Holdings first reported a position in Gilead Sciences in Q3 2022 and held it in 6 quarters.
  • FWG Holdings's Gilead Sciences position peaked at $319K in Q4 2022.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on FWG Holdings's 13F filing for Q1 2024, filed 13 May 2024.